前往化源商城

Setiptiline-d3

更新时间:2024-04-01 15:54:23

Setiptiline-d3结构式
Setiptiline-d3结构式
品牌特惠专场
常用名 Setiptiline-d3 英文名 Setiptiline-d3
CAS号 1795024-97-3 分子量 264.38
密度 N/A 沸点 N/A
分子式 C19H16D3N 熔点 N/A
MSDS N/A 闪点 N/A

 Setiptiline-d3用途


塞提替林-d3(Org-8282-d3)是氘标记的塞提替林。塞提替林(Org-8282)是一种5-羟色胺受体拮抗剂。西替替林是一种四环抗抑郁剂(TeCA),作为去甲肾上腺素能和特异性5-羟色胺能抗抑郁剂(NaSSA)。西替替林可能在5-HT2A、5-HT2C和/或5-HT3亚型中起到去甲肾上腺素再摄取抑制剂、α2-肾上腺素能受体拮抗剂和5-羟色胺受体拮抗剂的作用,以及H1受体反向激动剂/抗组胺剂[1][2]。

 Setiptiline-d3名称

中文名 司普替林-D3
英文名 Setiptiline-d3

 Setiptiline-d3生物活性

描述 塞提替林-d3(Org-8282-d3)是氘标记的塞提替林。塞提替林(Org-8282)是一种5-羟色胺受体拮抗剂。西替替林是一种四环抗抑郁剂(TeCA),作为去甲肾上腺素能和特异性5-羟色胺能抗抑郁剂(NaSSA)。西替替林可能在5-HT2A、5-HT2C和/或5-HT3亚型中起到去甲肾上腺素再摄取抑制剂、α2-肾上腺素能受体拮抗剂和5-羟色胺受体拮抗剂的作用,以及H1受体反向激动剂/抗组胺剂[1][2]。
相关类别
体外研究 氢、碳和其他元素的稳定重同位素已被纳入药物分子,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
参考文献

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Yamada K, Furukawa T. [Behavioral effects of a new antidepressant, setiptiline]. Nihon Yakurigaku Zasshi. 1991 Jan;97(1):31-9.

[3]. Kamimura M, Aoba A, Yamaguchi N et al. The effect of age on plasma level of setiptiline maleate in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct;18(6):1015-26.

[4]. Kuniyoshi M, Nakamura J, Miura C, Inanaga K. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Mar;18(2):339-46.

[5]. Niho T, Ito C, Shibutani Y, Hashizume H, Yamaguchi K. [Pharmacological properties of MO-8282, a novel antidepressant]. Nihon Yakurigaku Zasshi. 1986 Oct;88(4):309-20.

 Setiptiline-d3物理化学性质

分子式 C19H16D3N
分子量 264.38
储存条件 -20°C,干燥,密封

 Setiptiline-d3安全信息

危害码 (欧洲) Xi
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:


查看所有供应商和价格请点击:

Setiptiline-d3生产厂家

Setiptiline-d3价格

相关化合物: 更多...
Setiptiline
57262-94-9
Setiptiline (maleate)
85650-57-3
phenylsilane-d3
18164-03-9
Raltegravir-d3(potassium salt)
1246816-98-7
Ropinirole-d3 hydrochloride
1329611-00-8
Sinensetin-d3
1438399-79-1
sulfonium-d3
75050-69-0
Safinamide d3
1147299-71-5
Mesalazine-d3 Hydrochloride
1346601-18-0
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,3R,4S)-4-Cyclopropyl-3,4-dihydroxy-1-methylbutyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol
154530-28-6
(4S,4aR,5S,6R,8aS)-6-(1,3-Dihydro-4-hydroxy-1-methyl-3-oxo-1-isobenzofuranyl)-4-(dimethylamino)-1,4,4a,5,6,8a-hexahydro-3,5,8,8a-tetrahydroxy-1-oxo-2-naphthalenecarboxamide
883907-60-6
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, 2-oxopropyl ester, [2S-(2I+/-,5I+/-,6I(2))]-
57808-42-1
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)oxoacetyl]amino]-3-ethenyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-trans)-
79350-16-6
N-[2-[[1-(Hydroxymethyl)-2-oxo-2-(1,5,6,8-tetrahydro-8-oxo-1,5-methano-2H-pyrido[1,2-a][1,5]diazocin-3(4H)-yl)ethyl]amino]-2-oxoethyl]-2-phenyl-4-quinolinecarboxamide
5687-47-8
rel-(3aR,3bS,6aS,7aR)-3a,3b,4,5,6,6a,7,7a-Octahydro-3,3a,3b,7a-tetrahydroxy-6,6-dimethyl-5-(1-methylethylidene)-2-(3-methyl-1-oxobutyl)-1H-cyclopenta[a]pentalen-1-one
83680-60-8
O-3-Deoxy-4-C-methyl-3-(methylamino)-I(2)-L-arabinopyranosyl-(1a6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-I+/--D-erythro-hexopyranosyl-(1a4)]-2-deoxy-N1,N3-diethyl-D-streptamine
1312695-20-7
5-cyclopentyl-1-methyl-1H-pyrazol-3-aminehydrochloride
2770359-56-1
Methyl (2E,3E,5E)-6-[(3S)-3,4-dihydro-4,4-dimethyl-3-[(3-methyl-2-buten-1-yl)oxy]-2H-1,5-benzodioxepin-7-yl]-3-(hydroxymethyl)-2-(methoxymethylene)-3,5-hexadienoate
113489-65-9
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-6-(formyloxy)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, [4S-(4I+/-,4aI+/-,5aI+/-,6I(2),12aI+/-)]-
40112-69-4